Fibrin ring granulomas in checkpoint inhibitor-induced hepatitis

American Journal of Surgical Pathology

Volumn 41, Issue 1, 2017, Pages 134-137

  Everett, Jamie ^a   Srivastava, Amitabh ^b   Misdraji, Joseph ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

fibrin ring granuloma; hepatitis; immune checkpoint inhibitor; ipilimumab; liver biopsy; nivolumab

Indexed keywords

ANTINEOPLASTIC AGENT; IPILIMUMAB; MONOCLONAL ANTIBODY; NIVOLUMAB;

ADULT; CASE REPORT; CHEMICALLY INDUCED; FEMALE; GRANULOMA; HUMAN; MALE; MELANOMA; MIDDLE AGED; PATHOLOGY; TOXIC HEPATITIS;

ADULT; ANTIBODIES, MONOCLONAL; ANTINEOPLASTIC AGENTS; CHEMICAL AND DRUG INDUCED LIVER INJURY; FEMALE; GRANULOMA; HUMANS; MALE; MELANOMA; MIDDLE AGED;

EID: 84992692374     PISSN: 01475185     EISSN: 15320979     Source Type: Journal    
DOI: 10.1097/PAS.0000000000000759     Document Type: Article

References (25)

1. Pellegrin M, Delsol G, Auvergnat JC, et al. Granulomatous hepatitis in Q fever. Hum Pathol. 1980; 11: 51-57.
2. Lee M, Jang JJ, Kim YS, et al. Clinicopathologic features of Q fever patients with acute hepatitis. Korean J Pathol. 2012; 46: 10-14.
3. Aguilar-Olivos N, del Carmen Manzano-Robleda M, Gutierrez-Grobe Y, et al. Granulomatous hepatitis caused by Q fever: a differential diagnosis of fever of unknown origin. Ann Hepatol. 2013; 12: 138-141.
4. Bernstein M, Edmondson HA, Barbour BH. The liver lesion in Q fever. Clinical and pathologic features. Arch Intern Med. 1965; 116: 491-498.
5. Ruel M, Sevestre H, Henry-Biabaud E, et al. Fibrin ring granulomas in hepatitis A. Dig Dis Sci. 1992; 37: 1915-1917.
6. Font J, Bruguera M, Perez-Villa F, et al. Hepatic fibrin-ring granulomas caused by Staphylococcus epidermidis generalized infection. Gastroenterology. 1987; 93: 1449-1451.
7. Marazuela M, Moreno A, Yebra M, et al. Hepatic fibrin-ring granulomas: a clinicopathologic study of 23 patients. Hum Pathol. 1991; 22: 607-613.
8. Restrepo MI, Vasquez EM, Echeverri C, et al. Fibrin ring granulomas in Rickettsia typhi infection. Diagn Microbiol Infect Dis. 2010; 66: 322-325.
9. Nenert M, Mavier P, Dubuc N, et al. Epstein-Barr virus infection and hepatic fibrin-ring granulomas. Hum Pathol. 1988; 19: 608-610.
10. Vanderstigel M, Zafrani ES, Lejonc JL, et al. Allopurinol hypersensitivity syndrome as a cause of hepatic fibrin-ring granulomas. Gastroenterology. 1986; 90: 188-190.
11. de Bayser L, Roblot P, Ramassamy A, et al. Hepatic fibrin-ring granulomas in giant cell arteritis. Gastroenterology. 1993; 105: 272-273.
12. Glazer E, Ejaz A, Coley CJ II, et al. Fibrin ring granuloma in chronic hepatitis C: virus-related vasculitis and/or immune complex disease?. Semin Liver Dis. 2007; 27: 227-230.
13. Tjwa M, De Hertogh G, Neuville B, et al. Hepatic fibrin-ring granulomas in granulomatous hepatitis: report of four cases and review of the literature. Acta Clin Belg. 2001; 56: 341-348.
14. Ponz E, Garcia-Pagan JC, Bruguera M, et al. Hepatic fibrin-ring granulomas in a patient with hepatitis A. Gastroenterology. 1991; 100: 268-270.
15. Moreno A, Marazuela M, Yebra M, et al. Hepatic fibrin-ring granulomas in visceral leishmaniasis. Gastroenterology. 1988; 95: 1123-1126.
16. Srigley JR, Vellend H, Palmer N, et al. Q-fever. The liver and bone marrow pathology. Am J Surg Pathol. 1985; 9: 752-758.
17. Delsol G, Pellegrin M, Voigt JJ, et al. Diagnostic value of granuloma with fibrinoid ring. Am J Clin Pathol. 1980; 73: 289.
18. Hofmann CE, Heaton JW Jr. Q fever hepatitis: clinical manifestations and pathological findings. Gastroenterology. 1982; 83: 474-479.
19. Qizilbash AH. The pathology of Q fever as seen on liver biopsy. Arch Pathol Lab Med. 1983; 107: 364-367.
20. Travis LB, Travis WD, Li CY, et al. Q fever. A clinicopathologic study of five cases. Arch Pathol Lab Med. 1986; 110: 1017-1020.
21. Lobdell DH. 'Ring' granulomas in cytomegalovirus hepatitis. Arch Pathol Lab Med. 1987; 111: 881-882.
22. Weber J. Review: anti-CTLA-4 antibody ipilimumab: case studies of clinical response and immune-related adverse events. Oncologist. 2007; 12: 864-872.
23. Wolchok JD, Kluger H, Callahan MK, et al. Nivolumab plus ipilimumab in advanced melanoma. New Engl J Med. 2013; 369: 122-133.
24. Johncilla M, Misdraji J, Pratt DS, et al. Ipilimumab-associated hepatitis: clinicopathologic characterization in a series of 11 cases. Am J Surg Pathol. 2015; 39: 1075-1084.
25. Khanlari B, Bodmer M, Terracciano L, et al. Hepatitis with fibrinring granulomas. Infection. 2008; 36: 381-383.